Top compounds associated with response to SYTL5


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.095 0.004
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.094 0.005
mRNA tandutinib CTRPv2 pan-cancer AAC -0.1 0.005
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA Rapamycin gCSI pan-cancer AAC -0.17 0.007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.007
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.094 0.008
mRNA CD-437 CTRPv2 pan-cancer AAC -0.084 0.009
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.009
Download CSV